Thomas Durcan is an associate professor at the Montreal Neurological Institute (The Neuro), McGill University, Canada. Originally from Dublin, Ireland, Dr. Durcan received his BSc from University College Dublin before moving to the U.S. and obtained his PhD in cell and molecular biology from the University of Notre Dame. He then joined Dr. Fon’s research group as a postdoctoral researcher before becoming the associate director of the Neuro’s Early Drug Discovery Unit. In his current research, he uses stem cells and 3D brain organoid models to understand how the genes and pathways associated with Parkinson's disease might be affected in these disease models. His research is supported by The Michael J. Fox Foundation, the U.S. Department of Defense and the Canadian Institutes of Health Research.
Associated Grants
-
-
-
Effects of LRRK2 Variants on GCase Activity in iPSC-derived Dopamine Neurons and Microglia
2020
-
Small-Molecule Inhibitor of Alpha-Synuclein Propagation in the Treatment of Parkinson's Disease
2017